Women's Cancer
Adding pembrolizumab to chemoradiotherapy improves outcomes in high-risk cervical cancer
The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced cervical cancer, according to data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Adding cisplatin to radiation fails to extend survival in intermediate-risk cervical cancer
The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, early-stage cervical cancer who underwent radical hysterectomy, according to randomized phase 3 study results.
AK104 with concurrent radiotherapy shows efficacy in locally advanced cervical cancer
The addition of AK104 to concurrent chemoradiotherapy improved survival outcomes for patients with locally advanced cervical cancer, according to data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Risk-based approach could reduce racial disparities in endometrial cancer care
Clinicians should adopt a risk-based, rather than biopsy-first, approach to encourage biopsy acceptance and improve early diagnosis of endometrial cancer among Black women, according to researchers.
Combination GLP-1, hormone therapy may reduce risk for endometrial cancer
The addition of glucagon-like peptide-1 receptor agonists to progestin therapy may help reduce endometrial cancer risk among certain women, according to study results.
Greater physical activity, less sedentary time may protect against breast cancer
Being more active and spending less time sedentary reduced women’s risk for breast cancer, according to data published in the British Journal of Sports Medicine.